Biosyntech (Biosyntech) Interest Expense : $-0.16 Mil (TTM As of Dec. 2009)

View and export this data going back to 2000. Start your Free Trial

What is Biosyntech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Biosyntech's interest expense for the three months ended in Dec. 2009 was $ -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2009 was $-0.16 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Biosyntech's Operating Income for the three months ended in Dec. 2009 was $ -3.17 Mil. Biosyntech's Interest Expense for the three months ended in Dec. 2009 was $ -0.04 Mil. Biosyntech did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biosyntech Interest Expense Historical Data

The historical data trend for Biosyntech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech Interest Expense Chart

Biosyntech Annual Data

Trend

Mar00

Mar01

Mar02

Mar03

Mar04

Mar05

Mar06

Mar07

Mar08

Mar09

Interest Expense

Get a 7-Day Free Trial

-0.38

-0.20

Biosyntech Quarterly Data
	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09
Interest Expense	Get a 7-Day Free Trial															-0.05	-0.04	-0.04	-0.04	-0.04

Biosyntech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.16 Mil.

Biosyntech (OTCPK:BSYI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biosyntech's Interest Expense for the three months ended in Dec. 2009 was $-0.04 Mil. Its Operating Income for the three months ended in Dec. 2009 was $-3.17 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2009 was $1.42 Mil.

Biosyntech's Interest Coverage for the quarter that ended in Dec. 2009 is calculated as

Biosyntech did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Biosyntech (Biosyntech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3

Website

http://www.biosyntech.com

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines